• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLBELLA W/LIDO 2X1ML EAME SKU1; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLBELLA W/LIDO 2X1ML EAME SKU1; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 96658JR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Skin Inflammation/ Irritation (4545)
Event Date 12/03/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reports patient injected with 1 ml of juvéderm® volbella¿ with lidocaine in the dark circles.Injection site confirmed to be "asepsis" prior to injection.During injection, tyndall effect and granulomas formed that did not improve with manual massage.No report of biopsy of granulomas to confirm.The next morning, patient presented with edema at the injection site with granulomas and tyndall effect persists.The surrounding area was swollen and bluish.Event ongoing.
 
Event Description
Additionally, healthcare professional reported they treated the patient with hyaluronidase and event has resolved completely as there was no "granuloma, it was product superficially placed.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLBELLA W/LIDO 2X1ML EAME SKU1
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
MDR Report Key11078107
MDR Text Key223800117
Report Number3005113652-2020-00815
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2022
Device Catalogue Number96658JR
Device Lot NumberV15LB00070
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/04/2020
Initial Date FDA Received12/28/2020
Supplement Dates Manufacturer Received01/15/2021
Supplement Dates FDA Received02/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age35 YR
-
-